<DOC>
	<DOC>NCT00203086</DOC>
	<brief_summary>It is thought that treating Multiple Sclerosis with Novantrone for a short period of time prior to treatment with Copaxone may enhance the onset effect of Copaxone.</brief_summary>
	<brief_title>A Study to Evaluate the Long Term Safety and Effectiveness of Novantrone Therapy Followed by Copaxone Treatment for Multiple Sclerosis</brief_title>
	<detailed_description />
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis, Relapsing-Remitting</mesh_term>
	<mesh_term>Glatiramer Acetate</mesh_term>
	<mesh_term>Mitoxantrone</mesh_term>
	<criteria>Participation &amp; completion of the NC100 Clinical Trial. Able and willing to sign an Informed Consent.</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>57 Years</maximum_age>
	<verification_date>April 2010</verification_date>
</DOC>